Trial Profile
5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 15 Nov 2017
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
- Indications Rectal cancer
- Focus Therapeutic Use
- 14 Jun 2013 Status changed from active, no longer recruiting to discontinued according to results presented at ASCO 2013.
- 05 Jun 2009 Interim results reported at the 45th Annual Meeting of the American Society of Clinical Oncology.
- 05 Jun 2009 New trial record.